Daniel Bundó
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Daniel Bundó has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Ariadna Arbiol-Roca
Territorial Clinical Laboratory Metropolitan South – Bellvitge University Hospital , Barcelona , Spain
1 shared publication - Betlem Salvador-González
MARCEVAP Research Group IDIAP Jordi Gol Barcelona Spain
1 shared publication - Inés Rama
Nephrology Department, Hospital Universitari de Bellvitge, Institut Català de la Salut, 08907 L’Hospitalet de Llobregat, Barcelona, Spain
1 shared publication - Jordi Comas
Catalan Renal Registry, Catalan Transplant Organization, Health Department, Generalitat of Catalonia, Barcelona, Spain
1 shared publication - Jose Romano
Malaltia Cardiovascular i Renal en Atenció Primària (MACAP), Institut Universitari d’Investigació en Atenció Primària (IDIAP) Jordi Gol, 08007 Barcelona, Barcelona, Spain
1 shared publication - Josep Maria Cruzado
Nephrology Department, Renal Transplant Unit, Bellvitge University Hospital, Barcelona, Spain
1 shared publication
Latest Publications
- Open Access
- 11 July 2023
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (14) , 4602
Final Stage of Chronic Kidney Disease with Conservative Kidney Management or Renal Replacement Therapy: A Primary-Care Population Study
Background: Studies focus on the incidence and risk factors (RFs) associated with reaching the final stage of chronic kidney disease (CKD-G5) and receiving kidney replacement therapy (KRT). Analysis of those related to reaching CKD-G5 while receiving conservative kidney management (CKM) has been neglected. Methods: Retrospective cohort study analysing electronic health records of individuals aged ≥ 50 with eGFR < 60 mL/min/m2. Cumulative incidence rates of CKD-G5, with and without KRT, were calculated. Multinomial regression models determined odds ratios (ORs) for CKD-G5 progression with KRT, CKM, or death. Results: Among 332,164 patients, the cumulative incidence of CKD-G5 was 2.79 cases per 100 person-years. The rates were 1.92 for CKD-G5 with KRT and 0.87 for CKD-G5 with CKM. Low eGFR and albuminuria were the primary RFs. Male gender and uncontrolled blood pressure had a greater impact on KRT (OR = 2.63 CI, 1.63) than on CKD-G5 with CKM (OR = 1.45 CI, 1.31). Increasing age and rurality reduced the probability of KRT but increased the probability of CKD-G5 with CKM. Higher incomes decreased the likelihood of developing CKD-G5 with and without KRT (OR = 0.49 CI). Conclusion: One-third of CKD-G5 cases receive CKM. Those are typically older, female, rural residents with lower incomes and with lesser proteinuria or cardiovascular RF. The likelihood of receiving KRT is influenced by location and socioeconomic disparities.
- 11 July 2023
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (14) , 4602
Open AccessFinal Stage of Chronic Kidney Disease with Conservative Kidney Management or Renal Replacement Therapy: A Primary-Care Population Study
Background: Studies focus on the incidence and risk factors (RFs) associated with reaching the final stage of chronic kidney disease (CKD-G5) and receiving kidney replacement therapy (KRT). Analysis of those related to reaching CKD-G5 while receiving conservative kidney management (CKM) has been neglected. Methods: Retrospective cohort study analysing electronic health records of individuals aged ≥ 50 with eGFR < 60 mL/min/m2. Cumulative incidence rates of CKD-G5, with and without KRT, were calculated. Multinomial regression models determined odds ratios (ORs) for CKD-G5 progression with KRT, CKM, or death. Results: Among 332,164 patients, the cumulative incidence of CKD-G5 was 2.79 cases per 100 person-years. The rates were 1.92 for CKD-G5 with KRT and 0.87 for CKD-G5 with CKM. Low eGFR and albuminuria were the primary RFs. Male gender and uncontrolled blood pressure had a greater impact on KRT (OR = 2.63 CI, 1.63) than on CKD-G5 with CKM (OR = 1.45 CI, 1.31). Increasing age and rurality reduced the probability of KRT but increased the probability of CKD-G5 with CKM. Higher incomes decreased the likelihood of developing CKD-G5 with and without KRT (OR = 0.49 CI). Conclusion: One-third of CKD-G5 cases receive CKM. Those are typically older, female, rural residents with lower incomes and with lesser proteinuria or cardiovascular RF. The likelihood of receiving KRT is influenced by location and socioeconomic disparities.